{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:42:10Z","timestamp":1788316930538,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institutes of Health \u2013 National Cancer Institute","award":["P30CA012197"],"award-info":[{"award-number":["P30CA012197"]}]},{"name":"National Institutes of Health \u2013 National Cancer Institute","award":["K25CA204599"],"award-info":[{"award-number":["K25CA204599"]}]},{"name":"WFBMCCC SBT Pilot grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Current tools to assess breast cancer response to neoadjuvant chemotherapy cannot reliably predict disease eradication, which if possible, could allow early cessation of therapy. In this work, we assessed the ability of an image data-driven mathematical modeling approach for dynamic characterization of breast cancer response to neoadjuvant therapy. We retrospectively analyzed patients enrolled in the I-SPY 2 TRIAL at the Atrium Health Wake Forest Baptist Comprehensive Cancer Center. Patients enrolled on the study received four MR imaging examinations during neoadjuvant therapy with\u00a0acquisitions\u00a0at baseline (T<jats:sub>0<\/jats:sub>),\u00a03-weeks\/early-treatment (T<jats:sub>1<\/jats:sub>),\u00a012-weeks\/mid-treatment (T<jats:sub>2<\/jats:sub>), and completion\u00a0of therapy prior to surgery (T<jats:sub>3<\/jats:sub>). We use a biophysical mathematical model of tumor growth to generate spatial estimates of tumor proliferation to characterize the dynamics of treatment response. Using histogram summary metrics to quantify estimated tumor proliferation maps, we found strong correlation of mathematical model-estimated tumor proliferation with residual cancer burden, with Pearson correlation coefficients ranging from 0.88 and 0.97 between T<jats:sub>0<\/jats:sub>and T<jats:sub>2<\/jats:sub>, representing a significant improvement from conventional assessment methods of change in mean apparent diffusion coefficient and functional tumor volume. This data shows the significant promise of imaging-based biophysical mathematical modeling methods for dynamic characterization of patient-specific response to neoadjuvant therapy with correlation to residual disease outcomes.<\/jats:p>","DOI":"10.1038\/s41598-022-15801-7","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T11:02:54Z","timestamp":1657364574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dynamic characterization of breast cancer response to neoadjuvant therapy using biophysical metrics of spatial proliferation"],"prefix":"10.1038","volume":"12","author":[{"given":"Haley J.","family":"Bowers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Ansley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared A.","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,9]]},"reference":[{"key":"15801_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000507041","volume":"15","author":"C Matuschek","year":"2020","unstructured":"Matuschek, C. et al. Neoadjuvant Radio(chemo)therapy for breast cancer: An old concept revisited. Breast Care 15, 112\u2013117. https:\/\/doi.org\/10.1159\/000507041 (2020).","journal-title":"Breast Care"},{"key":"15801_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cpet.2018.02.006","volume":"13","author":"T-A Moo","year":"2018","unstructured":"Moo, T.-A., Sanford, R., Dang, C. & Morrow, M. Overview of breast cancer therapy. PET Clin. 13, 339\u2013354. https:\/\/doi.org\/10.1016\/j.cpet.2018.02.006 (2018).","journal-title":"PET Clin."},{"key":"15801_CR3","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1200\/JCO.2015.63.1010","volume":"35","author":"WF Symmans","year":"2017","unstructured":"Symmans, W. F. et al. Long-term prognostic risk after neoadjuvant chemotherapy associated with residual cancer burden and breast cancer subtype. J. Clin. Oncol. 35, 1049\u20131060. https:\/\/doi.org\/10.1200\/JCO.2015.63.1010 (2017).","journal-title":"J. Clin. Oncol."},{"key":"15801_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10549-017-4303-8","volume":"165","author":"JI Campbell","year":"2017","unstructured":"Campbell, J. I. et al. Comparison of residual cancer burden, American joint committee on cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: Results from the I-SPY 1 TRIAL (CALGB 150007\/150012; ACRIN 6657). Breast Cancer Res. Treat. 165, 181\u2013191. https:\/\/doi.org\/10.1007\/s10549-017-4303-8 (2017).","journal-title":"Breast Cancer Res. Treat."},{"key":"15801_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3978\/j.issn.2072-1439.2010.02.03.8","volume":"2","author":"K Papademetriou","year":"2010","unstructured":"Papademetriou, K., Ardavanis, A. & Kountourakis, P. Neoadjuvant therapy for locally advanced breast cancer: Focus on chemotherapy and biological targeted treatments\u2019 armamentarium. J. Thorac. Dis. 2, 160\u2013170. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2010.02.03.8 (2010).","journal-title":"J. Thorac. Dis."},{"key":"15801_CR6","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1200\/JCO.2007.15.2983","volume":"26","author":"AC Wolff","year":"2008","unstructured":"Wolff, A. C. et al. Research issues affecting preoperative systemic therapy for operable breast cancer. J. Clin. Oncol. 26, 806\u2013813. https:\/\/doi.org\/10.1200\/JCO.2007.15.2983 (2008).","journal-title":"J. Clin. Oncol."},{"key":"15801_CR7","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/sj.bjc.6600210","volume":"86","author":"P Chollet","year":"2002","unstructured":"Chollet, P. et al. Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. Br. J. Cancer 86, 1041\u20131046. https:\/\/doi.org\/10.1038\/sj.bjc.6600210 (2002).","journal-title":"Br. J. Cancer"},{"key":"15801_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1148\/radiol.2017170180","volume":"285","author":"AM Fowler","year":"2017","unstructured":"Fowler, A. M., Mankoff, D. A. & Joe, B. N. Imaging neoadjuvant therapy response in breast cancer. Radiology 285, 358\u2013375. https:\/\/doi.org\/10.1148\/radiol.2017170180 (2017).","journal-title":"Radiology"},{"key":"15801_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1148\/radiol.2019182947","volume":"292","author":"RM Mann","year":"2019","unstructured":"Mann, R. M., Cho, N. & Moy, L. Breast MRI: State of the Art. Radiology 292, 520\u2013536. https:\/\/doi.org\/10.1148\/radiol.2019182947 (2019).","journal-title":"Radiology"},{"key":"15801_CR10","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/S0140-6736(11)61350-0","volume":"378","author":"M Morrow","year":"2011","unstructured":"Morrow, M., Waters, J. & Morris, E. MRI for breast cancer screening, diagnosis, and treatment. The Lancet 378, 1804\u20131811. https:\/\/doi.org\/10.1016\/S0140-6736(11)61350-0 (2011).","journal-title":"The Lancet"},{"key":"15801_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7150\/jca.7047","volume":"5","author":"LJ Graham","year":"2014","unstructured":"Graham, L. J. et al. Current approaches and challenges in monitoring treatment responses in breast cancer. J. Cancer 5, 58\u201368. https:\/\/doi.org\/10.7150\/jca.7047 (2014).","journal-title":"J. Cancer"},{"key":"15801_CR12","doi-asserted-by":"publisher","unstructured":"Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur. J. Cancer 45, 228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026 (2009).","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"15801_CR13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.breast.2012.07.006","volume":"21","author":"ML Marinovich","year":"2012","unstructured":"Marinovich, M. L. et al. Early prediction of pathologic response to neoadjuvant therapy in breast cancer: Systematic review of the accuracy of MRI. The Breast 21, 669\u2013677. https:\/\/doi.org\/10.1016\/j.breast.2012.07.006 (2012).","journal-title":"The Breast"},{"key":"15801_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13058-018-1091-y","volume":"21","author":"SP Gampenrieder","year":"2019","unstructured":"Gampenrieder, S. P. et al. Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR). Breast Cancer Res. 21, 19. https:\/\/doi.org\/10.1186\/s13058-018-1091-y (2019).","journal-title":"Breast Cancer Res."},{"key":"15801_CR15","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1148\/radiol.12110748","volume":"263","author":"NM Hylton","year":"2012","unstructured":"Hylton, N. M. et al. Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy\u2014Results from ACRIN 6657\/I-SPY TRIAL. Radiology 263, 663\u2013672. https:\/\/doi.org\/10.1148\/radiol.12110748 (2012).","journal-title":"Radiology"},{"key":"15801_CR16","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jmri.25560","volume":"46","author":"PJ Bolan","year":"2017","unstructured":"Bolan, P. J. et al. Magnetic resonance spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial. J. Magn. Reson. Imaging 46, 290\u2013302. https:\/\/doi.org\/10.1002\/jmri.25560 (2017).","journal-title":"J. Magn. Reson. Imaging"},{"key":"15801_CR17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0144","author":"C Yam","year":"2021","unstructured":"Yam, C. et al. Immune phenotype and response to neoadjuvant therapy in triple-negative breast cancer. Clin. Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-0144 (2021).","journal-title":"Clin. Cancer Res."},{"key":"15801_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/clpt.2009.68","volume":"86","author":"A Barker","year":"2009","unstructured":"Barker, A. et al. I-SPY 2: An adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin. Pharmacol. Ther. 86, 97\u2013100. https:\/\/doi.org\/10.1038\/clpt.2009.68 (2009).","journal-title":"Clin. Pharmacol. Ther."},{"key":"15801_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12609-019-00334-2","volume":"11","author":"H Wang","year":"2019","unstructured":"Wang, H. & Yee, D. I-SPY 2: A neoadjuvant adaptive clinical trial designed to improve outcomes in high-risk breast cancer. Curr. Breast Cancer Rep. 11, 303\u2013310. https:\/\/doi.org\/10.1007\/s12609-019-00334-2 (2019).","journal-title":"Curr. Breast Cancer Rep."},{"key":"15801_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41523-020-00203-7","volume":"6","author":"W Li","year":"2020","unstructured":"Li, W. et al. Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: Results from the I-SPY 2 TRIAL. NPJ Breast Cancer 6, 63. https:\/\/doi.org\/10.1038\/s41523-020-00203-7 (2020).","journal-title":"NPJ Breast Cancer"},{"key":"15801_CR21","doi-asserted-by":"publisher","unstructured":"van la Parra, R. F. D. & Kuerer, H. M. Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials. Breast Cancer Res. 18, 28. https:\/\/doi.org\/10.1186\/s13058-016-0684-6 (2016).","DOI":"10.1186\/s13058-016-0684-6"},{"key":"15801_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejca.2016.09.034","volume":"69","author":"J Heil","year":"2016","unstructured":"Heil, J. et al. Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?. Eur. J. Cancer 69, 142\u2013150. https:\/\/doi.org\/10.1016\/j.ejca.2016.09.034 (2016).","journal-title":"Eur. J. Cancer"},{"key":"15801_CR23","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1007\/s00330-017-5251-8","volume":"28","author":"S-Y Kim","year":"2018","unstructured":"Kim, S.-Y. et al. Contrast-enhanced MRI after neoadjuvant chemotherapy of breast cancer: Lesion-to-background parenchymal signal enhancement ratio for discriminating pathological complete response from minimal residual tumour. Eur. Radiol. 28, 2986\u20132995. https:\/\/doi.org\/10.1007\/s00330-017-5251-8 (2018).","journal-title":"Eur. Radiol."},{"key":"15801_CR24","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1088\/0031-9155\/58\/17\/5851","volume":"58","author":"JA Weis","year":"2013","unstructured":"Weis, J. A. et al. A mechanically coupled reaction\u2013diffusion model for predicting the response of breast tumors to neoadjuvant chemotherapy. Phys. Med. Biol. 58, 5851\u20135866. https:\/\/doi.org\/10.1088\/0031-9155\/58\/17\/5851 (2013).","journal-title":"Phys. Med. Biol."},{"key":"15801_CR25","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1158\/0008-5472.CAN-14-2945","volume":"75","author":"JA Weis","year":"2015","unstructured":"Weis, J. A. et al. Predicting the response of breast cancer to neoadjuvant therapy using a mechanically coupled reaction-diffusion model. Cancer Res. 75, 4697\u20134707. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-2945 (2015).","journal-title":"Cancer Res."},{"key":"15801_CR26","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.cma.2016.08.024","volume":"314","author":"JA Weis","year":"2017","unstructured":"Weis, J. A., Miga, M. I. & Yankeelov, T. E. Three-dimensional image-based mechanical modeling for predicting the response of breast cancer to neoadjuvant therapy. Comput. Meth. Appl. Mech. Eng. 314, 494\u2013512. https:\/\/doi.org\/10.1016\/j.cma.2016.08.024 (2017).","journal-title":"Comput. Meth. Appl. Mech. Eng."},{"key":"15801_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1158\/1078-0432.CCR-14-3336","volume":"22","author":"TE Yankeelov","year":"2016","unstructured":"Yankeelov, T. E. et al. Quantitative imaging in cancer clinical trials. Clin. Cancer Res. 22, 284\u2013290 (2016).","journal-title":"Clin. Cancer Res."},{"key":"15801_CR28","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neo.2020.10.011","volume":"22","author":"AM Jarrett","year":"2020","unstructured":"Jarrett, A. M. et al. Evaluating patient-specific neoadjuvant regimens for breast cancer via a mathematical model constrained by quantitative magnetic resonance imaging data. Neoplasia 22, 820\u2013830. https:\/\/doi.org\/10.1016\/j.neo.2020.10.011 (2020).","journal-title":"Neoplasia"},{"key":"15801_CR29","doi-asserted-by":"publisher","unstructured":"Yankeelov, T. E. et al. Clinically relevant modeling of tumor growth and treatment response. Sci. Transl. Med. 5, 187ps189. https:\/\/doi.org\/10.1126\/scitranslmed.3005686 (2013).","DOI":"10.1126\/scitranslmed.3005686"},{"key":"15801_CR30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1593\/tlo.13130","volume":"6","author":"NC Atuegwu","year":"2013","unstructured":"Atuegwu, N. C. et al. Parameterizing the logistic model of tumor growth by DW-MRI and DCE-MRI data to predict treatment response and changes in breast cancer cellularity during neoadjuvant chemotherapy. Transl. Oncol. 6, 256\u2013264 (2013).","journal-title":"Transl. Oncol."},{"key":"15801_CR31","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/s1053-8119(02)91132-8","volume":"17","author":"M Jenkinson","year":"2002","unstructured":"Jenkinson, M., Bannister, P., Brady, M. & Smith, S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17, 825\u2013841. https:\/\/doi.org\/10.1016\/s1053-8119(02)91132-8 (2002).","journal-title":"Neuroimage"},{"key":"15801_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","volume":"5","author":"M Jenkinson","year":"2001","unstructured":"Jenkinson, M. & Smith, S. A global optimisation method for robust affine registration of brain images. Med. Image Anal. 5, 143\u2013156. https:\/\/doi.org\/10.1016\/S1361-8415(01)00036-6 (2001).","journal-title":"Med. Image Anal."},{"key":"15801_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuroimage.2009.06.060","volume":"48","author":"DN Greve","year":"2009","unstructured":"Greve, D. N. & Fischl, B. Accurate and robust brain image alignment using boundary-based registration. Neuroimage 48, 63\u201372. https:\/\/doi.org\/10.1016\/j.neuroimage.2009.06.060 (2009).","journal-title":"Neuroimage"},{"key":"15801_CR34","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.media.2010.07.002","volume":"15","author":"Y Ou","year":"2011","unstructured":"Ou, Y., Sotiras, A., Paragios, N. & Davatzikos, C. DRAMMS: Deformable registration via attribute matching and mutual-saliency weighting. Med. Image Anal. 15, 622\u2013639. https:\/\/doi.org\/10.1016\/j.media.2010.07.002 (2011).","journal-title":"Med. Image Anal."},{"key":"15801_CR35","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/mrm.24782","volume":"71","author":"X Li","year":"2014","unstructured":"Li, X. et al. DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: Pilot study findings. Magn. Reson. Med. 71, 1592\u20131602. https:\/\/doi.org\/10.1002\/mrm.24782 (2014).","journal-title":"Magn. Reson. Med."},{"key":"15801_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1088\/0031-9155\/57\/1\/225","volume":"57","author":"NC Atuegwu","year":"2012","unstructured":"Atuegwu, N. C. et al. Incorporation of diffusion-weighted magnetic resonance imaging data into a simple mathematical model of tumor growth. Phys. Med. Biol. 57, 225\u2013240. https:\/\/doi.org\/10.1088\/0031-9155\/57\/1\/225 (2012).","journal-title":"Phys. Med. Biol."},{"key":"15801_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/(sici)1097-0320(19970601)28:2<141::aid-cyto7>3.0.co;2-i","volume":"28","author":"I Martin","year":"1997","unstructured":"Martin, I., Dozin, B., Quarto, R., Cancedda, R. & Beltrame, F. Computer-based technique for cell aggregation analysis and cell aggregation in in vitro chondrogenesis. Cytometry 28, 141\u2013146. https:\/\/doi.org\/10.1002\/(sici)1097-0320(19970601)28:2%3c141::aid-cyto7%3e3.0.co;2-i (1997).","journal-title":"Cytometry"},{"key":"15801_CR38","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0730-725X(00)00147-8","volume":"18","author":"A Anderson","year":"2000","unstructured":"Anderson, A. et al. Effect of cell volume fraction changes on apparent diffusion in human cells. Magn. Reson. Imaging 18, 689\u2013695. https:\/\/doi.org\/10.1016\/S0730-725X(00)00147-8 (2000).","journal-title":"Magn. Reson. Imaging"},{"key":"15801_CR39","doi-asserted-by":"crossref","unstructured":"Garg, I. & Miga, M. I. in Medical Imaging 2008: Visualization, Image-Guided Procedures, and Modeling. 69182L (International Society for Optics and Photonics).","DOI":"10.1117\/12.773376"},{"key":"15801_CR40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/BF01589116","volume":"45","author":"DC Liu","year":"1989","unstructured":"Liu, D. C. & Nocedal, J. On the limited memory BFGS method for large scale optimization. Math. Program. 45, 503\u2013528. https:\/\/doi.org\/10.1007\/BF01589116 (1989).","journal-title":"Math. Program."},{"key":"15801_CR41","unstructured":"Lions, J. L. & Magenes, E. Non-homogeneous boundary value problems and applications: Vol. 1. (Springer Science & Business Media, 2012)."},{"key":"15801_CR42","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1148\/radiol.2018180273","volume":"289","author":"SC Partridge","year":"2018","unstructured":"Partridge, S. C. et al. Diffusion-weighted MRI findings predict pathologic response in neoadjuvant treatment of breast cancer: The ACRIN 6698 multicenter trial. Radiology 289, 618\u2013627. https:\/\/doi.org\/10.1148\/radiol.2018180273 (2018).","journal-title":"Radiology"},{"key":"15801_CR43","doi-asserted-by":"crossref","unstructured":"Hylton, N. M. Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. Magn. Reson. Imaging Clin. N. Am. 7, 411\u2013420 (1999).","DOI":"10.1016\/S1064-9689(21)00031-3"},{"key":"15801_CR44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1148\/radiol.2015150013","volume":"279","author":"NM Hylton","year":"2016","unstructured":"Hylton, N. M. et al. Neoadjuvant chemotherapy for breast cancer: functional tumor volume by MR imaging predicts recurrence-free survival\u2014results from the ACRIN 6657\/CALGB 150007 I-SPY 1 TRIAL. Radiology 279, 44\u201355. https:\/\/doi.org\/10.1148\/radiol.2015150013 (2016).","journal-title":"Radiology"},{"key":"15801_CR45","unstructured":"Residual Cancer Burden Calculator, www.mdanderson.org\/breastcancer_RCB."},{"key":"15801_CR46","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1200\/jco.2007.10.6823","volume":"25","author":"WF Symmans","year":"2007","unstructured":"Symmans, W. F. et al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J. Clin. Oncol. 25, 4414\u20134422. https:\/\/doi.org\/10.1200\/jco.2007.10.6823 (2007).","journal-title":"J. Clin. Oncol."},{"key":"15801_CR47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","volume":"31","author":"JV McGowan","year":"2017","unstructured":"McGowan, J. V. et al. Anthracycline chemotherapy and cardiotoxicity. Cardiovasc. Drugs Ther. 31, 63\u201375. https:\/\/doi.org\/10.1007\/s10557-016-6711-0 (2017).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"15801_CR48","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1200\/JCO.2003.04.100","volume":"21","author":"M-C Deley","year":"2003","unstructured":"Deley, M.-C. et al. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: A case-control study by the societe francaise d\u2019oncologie pediatrique. J. Clin. Oncol. 21, 1074\u20131081. https:\/\/doi.org\/10.1200\/JCO.2003.04.100 (2003).","journal-title":"J. Clin. Oncol."},{"key":"15801_CR49","doi-asserted-by":"publisher","unstructured":"Pfob, A. et al. Intelligent vacuum-assisted biopsy to identify breast cancer patients with pathologic complete response (ypT0 and ypN0) after neoadjuvant systemic treatment for omission of breast and axillary surgery. J. Clin. Oncol. Jco2102439. https:\/\/doi.org\/10.1200\/jco.21.02439 (2022).","DOI":"10.1200\/jco.21.02439"},{"key":"15801_CR50","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1148\/radiol.2020192534","volume":"295","author":"JM Chang","year":"2020","unstructured":"Chang, J. M., Leung, J. W. T., Moy, L., Ha, S. M. & Moon, W. K. Axillary nodal evaluation in breast cancer: State of the art. Radiology 295, 500\u2013515. https:\/\/doi.org\/10.1148\/radiol.2020192534 (2020).","journal-title":"Radiology"},{"key":"15801_CR51","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1001\/jama.2013.277804","volume":"310","author":"R Rao","year":"2013","unstructured":"Rao, R., Euhus, D., Mayo, H. G. & Balch, C. Axillary node interventions in breast cancer: A systematic review. JAMA 310, 1385\u20131394. https:\/\/doi.org\/10.1001\/jama.2013.277804 (2013).","journal-title":"JAMA"},{"key":"15801_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0002-9610(01)00848-0","volume":"183","author":"WE Burak","year":"2002","unstructured":"Burak, W. E. et al. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am. J. Surg. 183, 23\u201327. https:\/\/doi.org\/10.1016\/s0002-9610(01)00848-0 (2002).","journal-title":"Am. J. Surg."},{"key":"15801_CR53","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.soc.2014.03.007","volume":"23","author":"AS Caudle","year":"2014","unstructured":"Caudle, A. S., Cupp, J. A. & Kuerer, H. M. Management of axillary disease. Surg. Oncol. Clin. N. Am. 23, 473\u2013486. https:\/\/doi.org\/10.1016\/j.soc.2014.03.007 (2014).","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"15801_CR54","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.acra.2014.10.010","volume":"22","author":"H Rahbar","year":"2015","unstructured":"Rahbar, H. et al. Suspicious axillary lymph nodes identified on clinical breast MRI in patients newly diagnosed with breast cancer: Can quantitative features improve discrimination of malignant from benign?. Acad. Radiol. 22, 430\u2013438. https:\/\/doi.org\/10.1016\/j.acra.2014.10.010 (2015).","journal-title":"Acad. Radiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15801-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15801-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15801-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T21:09:32Z","timestamp":1727557772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15801-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,9]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15801"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15801-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,9]]},"assertion":[{"value":"7 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11718"}}